why choose us

First received: February 06, 2024

Clinical Trial: IC14 (Atibuclimab) in Arrhythmogenic Cardiomyopathy

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Arrhythmogenic Right Ventricular Dysplasia

Study Type: INTERVENTIONAL


Official Title: Phase 1b Study of IC14 in Arrhythmogenic Cardiomyopathy

Brief Summary: The goal of this clinical trial is to test IC14 (atibuclimab) in patients with arrhythmogenic cardiomyopathy (ACM) and who have an implantable cardoverter/defibrillator in place.ACM is also called arrhythmogenic right ventricular dysplasia (ARV) or arrhythmogenic right ventricular cardiomyopathy (ARVC).The main questions the study aims to answer are the effect of treatment on blood markers of inflammation, safety, and pharmacokinetics.There will also be measurements of myocardial imaging of C-C chemokine…

Read more